Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1)

被引:67
作者
Fuse, H
Kitagawa, H
Kato, S
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
[2] Teikoku Hormone Mfg Co, Pharmacol Res Dept, Tokyo 1078522, Japan
关键词
D O I
10.1210/me.14.6.889
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The autonomous activation function-2 (AF-2) in the mineralocorticoid receptor (MR) UF domain is known to play a major role in the ligand-induced transactivation function of MR; however, it remained unclear about the transactivation function of its A/B domain. We therefore tried to characterize the MR A/B domain as the AF-1 and further studied the actions of known coactivators for AF-2 in the E/F ligand-binding domain in the function of the MR A/B domain. Deletion analyses of rat and human MRs revealed that the A/B domains harbor a transactivation function acting as AF-1. The MR mutant (E959Q) with a point mutation in helix 12, which causes a complete loss of MR AF-2 activity, still retained ligand-induced transactivation function, indicating a significant role for AF-1 in the full activity of the ligand-induced MR function. Among the coactivators tested to potentiate the MR AF-2, TIF2 and p300 potentiated the MR AF-1 through two different core regions [amino acids (a.a.) 1-169, a.a. 451-603] and exhibited functional interactions with the MR A/B domain in the cultured cells. However, such interactions were undetectable in a yeast and in an in vitro glutathione-S-transferase pull-down assay, indicating that the functional interaction of TIF2 and p300 with the MR A/B domain to support the MR AF-1 activity require some unknown nuclear factor(s) or a proper modification of the A/B domain in the cells.
引用
收藏
页码:889 / 899
页数:11
相关论文
共 47 条
  • [1] AGARWAL MK, 1994, PHARMACOL REV, V46, P67
  • [2] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [3] Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
    Baur, EV
    Zechel, C
    Heery, D
    Heine, MJS
    Garnier, JM
    Vivat, V
    LeDouarin, B
    Gronemeyer, H
    Chambon, P
    Losson, R
    [J]. EMBO JOURNAL, 1996, 15 (01) : 110 - 124
  • [4] NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR
    CAVAILLES, V
    DAUVOIS, S
    LHORSET, F
    LOPEZ, G
    HOARE, S
    KUSHNER, PJ
    PARKER, MG
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3741 - 3751
  • [5] Delineation of two distinct type I activation functions in the androgen receptor amino-terminal domain
    Chamberlain, NL
    Whitacre, DC
    Miesfeld, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) : 26772 - 26778
  • [6] Ebihara K, 1996, MOL CELL BIOL, V16, P3393
  • [7] Endoh H, 1999, MOL CELL BIOL, V19, P5363
  • [8] Increasing the complexity of coactivation in nuclear receptor signaling
    Freedman, LP
    [J]. CELL, 1999, 97 (01) : 5 - 8
  • [9] Aldosterone action: Fact, failure and the future
    Funder, JW
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 : S47 - S50
  • [10] Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor
    Giangrande, PH
    Pollio, G
    McDonnell, DP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) : 32889 - 32900